In addition to the age of diagnosis, FIGO stage, degree of differentiation, depth of myometrial invasion, lymph node metastasis and PR and ER status, high expression of TMEFF1 also affected the overall survival of patients with endometrial carcinoma and was an independent risk factor for prognosis. The gene discussed is ESR1; the disease is metastatic malignant neoplasm in the lymph nodes.